Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Chau

Showing results (111-120 of 266) with videos related to

Pageof 27
Sort By:
British Journal of Cancer|March 25, 2023
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trialsAvani Athauda, Matthew Nankivell, Rupert Langer, et al.
The Lancet. Oncology|January 29, 2010
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trialYu Jo Chua, Yolanda Barbachano, David Cunningham, et al.
Clinical Colorectal Cancer|November 15, 2016
Attitudes of Patients With Gastrointestinal Cancers Toward Research BiopsiesSing Yu Moorcraft, Ruwaida Begum, David Cunningham, et al.
Current Problems in Cancer|March 5, 2019
Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature reviewVasiliki Michalarea, Elisa Fontana, Alvaro Ingles Garces, et al.
Annals of Surgery|September 17, 2020
MRI-Diagnosed Tumor Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal CancerAmy C Lord, Nigel D'Souza, Annabel Shaw, et al.
Annals of Hematology|October 26, 2013
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphomaEliza A Hawkes, Sarah Barton, David Cunningham, et al.
Clinical Nuclear Medicine|March 6, 2015
The role of routine clinical pretreatment 18F-FDG PET/CT in predicting outcome of colorectal liver metastasisHenry H Tam, Gary J Cook, Ian Chau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancerIan Chau, Gina Brown, David Cunningham, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 7, 2015
Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010Elisa Fontana, Elizabeth C Smyth, David Cunningham, et al.
Clinical Colorectal Cancer|August 28, 2019
ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UKShelize Khakoo, Ian Chau, Ian Pedley, et al.
Pageof 27

Showing results (111-120 of 266) with videos related to

Sort By:
Pageof 27
British Journal of Cancer|March 25, 2023
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trialsAvani Athauda, Matthew Nankivell, Rupert Langer, et al.
The Lancet. Oncology|January 29, 2010
Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trialYu Jo Chua, Yolanda Barbachano, David Cunningham, et al.
Clinical Colorectal Cancer|November 15, 2016
Attitudes of Patients With Gastrointestinal Cancers Toward Research BiopsiesSing Yu Moorcraft, Ruwaida Begum, David Cunningham, et al.
Current Problems in Cancer|March 5, 2019
Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature reviewVasiliki Michalarea, Elisa Fontana, Alvaro Ingles Garces, et al.
Annals of Surgery|September 17, 2020
MRI-Diagnosed Tumor Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal CancerAmy C Lord, Nigel D'Souza, Annabel Shaw, et al.
Annals of Hematology|October 26, 2013
GEM-P chemotherapy is active in the treatment of relapsed Hodgkin lymphomaEliza A Hawkes, Sarah Barton, David Cunningham, et al.
Clinical Nuclear Medicine|March 6, 2015
The role of routine clinical pretreatment 18F-FDG PET/CT in predicting outcome of colorectal liver metastasisHenry H Tam, Gary J Cook, Ian Chau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancerIan Chau, Gina Brown, David Cunningham, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 7, 2015
Improved survival in resected oesophageal and gastric adenocarcinomas over a decade: the Royal Marsden experience 2001-2010Elisa Fontana, Elizabeth C Smyth, David Cunningham, et al.
Clinical Colorectal Cancer|August 28, 2019
ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UKShelize Khakoo, Ian Chau, Ian Pedley, et al.
Pageof 27